Westchester Capital Management (Nebraska)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100,150
| Closed | -$6.79M | – | 40 |
|
|
2025
Q1 | $6.79M | Sell |
100,150
-19,177
| -16% | -$1.15M | 1.69% | 23 |
|
|
2024
Q4 | $5.36M | Sell |
119,327
-3,359
| -3% | -$188K | 1.35% | 24 |
|
|
2024
Q3 | $7.71M | Sell |
122,686
-238
| -0.2% | -$13.9K | 1.87% | 22 |
|
|
2024
Q2 | $7.26M | Sell |
122,924
-1,504
| -1% | -$94.1K | 1.83% | 21 |
|
|
2024
Q1 | $9.92M | Sell |
124,428
-1,229
| -1% | -$93.9K | 2.49% | 20 |
|
|
2023
Q4 | $9.92M | Sell |
125,657
-2,198
| -2% | -$156K | 2.67% | 21 |
|
|
2023
Q3 | $8.93M | Sell |
127,855
-1,602
| -1% | -$114K | 2.56% | 20 |
|
|
2023
Q2 | $8.95M | Buy |
129,457
+632
| +0.5% | +$45K | 2.49% | 20 |
|
|
2023
Q1 | $9.57M | Buy |
128,825
+556
| +0.4% | +$46.6K | 2.75% | 20 |
|
|
2022
Q4 | $12M | Sell |
128,269
-1,029
| -0.8% | -$99.3K | 3.52% | 17 |
|
|
2022
Q3 | $12.3M | Sell |
129,298
-432
| -0.3% | -$42.8K | 3.98% | 12 |
|
|
2022
Q2 | $12M | Buy |
129,730
+2,068
| +2% | +$202K | 3.67% | 13 |
|
|
2022
Q1 | $12.9M | Sell |
127,662
-884
| -0.7% | -$92.9K | 3.33% | 16 |
|
|
2021
Q4 | $13.3M | Buy |
128,546
+2,213
| +2% | +$204K | 3.39% | 16 |
|
|
2021
Q3 | $10.7M | Buy |
126,333
+1,503
| +1% | +$126K | 2.99% | 21 |
|
|
2021
Q2 | $10.4M | Sell |
124,830
-2,260
| -2% | -$185K | 2.92% | 21 |
|
|
2021
Q1 | $9.56M | Buy |
127,090
+210
| +0.2% | +$15.3K | 2.77% | 21 |
|
|
2020
Q4 | $8.67M | Buy |
126,880
+2,047
| +2% | +$133K | 2.74% | 22 |
|
|
2020
Q3 | $7.29M | Buy |
124,833
+1,672
| +1% | +$104K | 2.59% | 22 |
|
|
2020
Q2 | $8M | Sell |
123,161
-1,565
| -1% | -$98.5K | 3.02% | 20 |
|
|
2020
Q1 | $7.4M | Buy |
124,726
+404
| +0.3% | +$27K | 3.31% | 17 |
|
|
2019
Q4 | $9.24M | Buy |
124,322
+3,735
| +3% | +$262K | 3.22% | 21 |
|
|
2019
Q3 | $7.61M | Buy |
120,587
+5,740
| +5% | +$340K | 2.98% | 22 |
|
|
2019
Q2 | $6.26M | Buy |
114,847
+8,880
| +8% | +$478K | 2.45% | 25 |
|
|
2019
Q1 | $5.71M | Buy |
105,967
+4,000
| +4% | +$247K | 2.45% | 24 |
|
|
2018
Q4 | $6.68M | Sell |
101,967
-2,477
| -2% | -$185K | 3.11% | 22 |
|
|
2018
Q3 | $8.22M | Buy |
104,444
+695
| +0.7% | +$49.7K | 3.26% | 21 |
|
|
2018
Q2 | $6.68M | Buy |
103,749
+745
| +0.7% | +$49.1K | 2.84% | 24 |
|
|
2018
Q1 | $6.41M | Sell |
103,004
-1,419
| -1% | -$102K | 2.7% | 24 |
|
|
2017
Q4 | $7.57M | Buy |
104,423
+48
| +0% | +$3.49K | 3.12% | 21 |
|
|
2017
Q3 | $8.49M | Buy |
104,375
+1,244
| +1% | +$98.4K | 3.64% | 13 |
|
|
2017
Q2 | $8.3M | Buy |
103,131
+3,697
| +4% | +$292K | 3.78% | 13 |
|
|
2017
Q1 | $7.81M | Buy |
99,434
+1,397
| +1% | +$112K | 3.75% | 15 |
|
|
2016
Q4 | $7.74M | Sell |
98,037
-3,375
| -3% | -$273K | 3.86% | 14 |
|
|
2016
Q3 | $9.03M | Sell |
101,412
-5,775
| -5% | -$545K | 4.39% | 7 |
|
|
2016
Q2 | $10.3M | Sell |
107,187
-1,550
| -1% | -$154K | 4.55% | 3 |
|
|
2016
Q1 | $11.3M | Buy |
108,737
+18,485
| +20% | +$1.8M | 5.08% | 2 |
|
|
2015
Q4 | $8.82M | Sell |
90,252
-1,393
| -2% | -$136K | 4.36% | 6 |
|
|
2015
Q3 | $8.84M | Sell |
91,645
-625
| -0.7% | -$65.7K | 4.73% | 2 |
|
|
2015
Q2 | $9.68M | Sell |
92,270
-1,001
| -1% | -$102K | 4.62% | 2 |
|
|
2015
Q1 | $9.63M | Sell |
93,271
-1,550
| -2% | -$157K | 4.76% | 2 |
|
|
2014
Q4 | $9.13M | Sell |
94,821
-2,314
| -2% | -$204K | 4.38% | 7 |
|
|
2014
Q3 | $7.73M | Sell |
97,135
-550
| -0.6% | -$43.4K | 3.66% | 9 |
|
|
2014
Q2 | $7.36M | Sell |
97,685
-381
| -0.4% | -$28.8K | 3.47% | 12 |
|
|
2014
Q1 | $7.34M | Sell |
98,066
-200
| -0.2% | -$14.1K | 3.69% | 8 |
|
|
2013
Q4 | $7.03M | Sell |
98,266
-418
| -0.4% | -$26.9K | 3.78% | 9 |
|
|
2013
Q3 | $5.6M | Sell |
98,684
-1,150
| -1% | -$68.5K | 3.47% | 18 |
|
|
2013
Q2 | $5.71M | Buy |
+99,834
| New | +$5.78M | 3.62% | 15 |
|
Other funds holding CVS
Westchester Capital Management (Nebraska)'s CVS Position: Q2 2025 in Review
Westchester Capital Management (Nebraska) sold out of CVS Health (CVS) in Q2 2025, closing a stake of 100,150 shares — an estimated $6.79M sold.
Westchester Capital Management (Nebraska) first reported a position in CVS in Q2 2013 and held it in 48 quarters. The position peaked at $13.3M in Q4 2021. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.
- Westchester Capital Management (Nebraska) reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
- Westchester Capital Management (Nebraska) sold 100,150 CVS Health shares in Q2 2025, an estimated $6.79M.
- Westchester Capital Management (Nebraska) first reported a position in CVS Health in Q2 2013 and held it in 48 quarters.
- Westchester Capital Management (Nebraska)'s CVS Health position peaked at $13.3M in Q4 2021.
- 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.
Based on Westchester Capital Management (Nebraska)'s 13F filing for Q2 2025, filed 25 Jul 2025.